Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2896
Selected: 0
NCT IDTitle
NCT01051414An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject
NCT04008992An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants
NCT04826536A Study of Treatment Patterns and Clinical Outcomes of Psoriasis in Japan
NCT03921684Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
NCT02345343Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico
NCT02588625A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT00298467MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma
NCT06764771A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
NCT02935634A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer
NCT03628209Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
NCT02574078A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT06523621Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
NCT04470778Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
NCT03165409Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread
NCT00095173BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
NCT00343083Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)
NCT02812524Ipilimumab for Head and Neck Cancer Patients
NCT02856451Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab
NCT00839683Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects
NCT00176254Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
NCT00213746Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)
NCT03070327BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma
NCT03730961An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
NCT05215470CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy
NCT01247766Safety Study of Abatacept to Treat Rheumatoid Arthritis
NCT02468986Study of Venous Endothelial Cells in Rheumatoid Arthritis
NCT02959554Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control
NCT02933346Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program
NCT04912765Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
NCT00764309Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis
NCT03400163A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
NCT02960230H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
NCT05560399A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
NCT02285985Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
NCT04021108Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
NCT07105059A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
NCT05168202A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
NCT02137239Regimen Optimization Study
NCT00357370A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes
NCT02368522Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)
NCT04043975A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan
NCT05407441Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
NCT03611751An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
NCT00457002Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
NCT03627806FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)
NCT03486912A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
NCT04150965Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT
NCT00362830A Study of the Alternative Administration of Ixabepilone and Vinflunine
NCT02998528A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
NCT03566264Study of the Sudden Heart Failure Participant Population in the US